Report Categories
View AllRecent Articles
View All
Direct Indexing Could Generate 19000 Annual Income on 700000 Portfolio
Longevity Biotech Stocks Rise Amid 27 Trillion Healthcare Shift Toward Cell Restoration
Cruz and Cantwells Potential College Football Legislation Raises Industry Concerns
Anthropics AI Advancements Pose Potential Challenge to Palantirs Market Position
Wingstop Shares Drop 12 as Profit Misses Market Expectations
ZDGE Q1 2026 Earnings EPS Misses Estimates Stock Declines 233
AGBK Q1 2026 Earnings EPS Surpasses Estimates by Over 6
NVCT Q1 2026 Earnings Narrower Loss Beats Estimates as Clinical Pipeline Advances
GLRE Q1 2026 Earnings Strong Profitability Drives Positive Market Response
RRR Q1 2026 Earnings Earnings Beat Estimates as Stock Rises 332
Danaher DHR Slightly Lower at 172 as Resistance Holds Firm
Amplitech Group Rights AMPGR Decline 781 as Stock Tests Key Support Levels
Aclarion Inc ACON Slips 156 as Shares Approach Key Support at 30
Voya Global Advantage Fund IGA Edges Higher at 988 Testing Support and Resistance Levels
Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model
SpaceX Files for Stock Market Debut Under Ticker SPCX Potentially Boosting Elon Musks Wealth
John Cornyn Faces Political Headwinds After Trump Criticism Amid Record Campaign Spending
AI Drug Discovery for Brain Conditions Draws Investor Interest
CZNC Q1 2026 Earnings Massive EPS Miss Amid Surprising Stock Resilience
TNXP Q1 2026 Earnings WiderThanExpected Loss Amid Continued Pipeline Development
CGNT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction
CNA Q1 2026 Earnings Earnings Miss Expectations as EPS Falls 34 Below Consensus
GKOS Q1 2026 Earnings EPS Beat Masks Broader Concerns as Stock Drops 135
Alzamend Neuro Inc ALZN Q1 2026 Earnings NarrowerthanExpected Loss as EarlyStage Biotech Continues RD Focus
External Links
UP Refutes Attorney General Claims Affirms Full Disclosure in Merger Documentation
NEN Q4 2024 Earnings Strong PerUnit Earnings Highlight Steady Real Estate Performance
Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips
ACR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amidst Commercial Real Estate Headwinds
KMT Q1 2026 Earnings Earnings Beat Estimates by 1345 Shares Edge Higher
Playtika Q1 2026 Earnings EPS Misses Estimates by 518 as Stock Declines
RES Q1 2026 Earnings EPS Surprises to the Upside Amid Challenging Oilfield Environment
MBINN Q1 2026 Earnings EPS Surpasses Estimates with 502 Surprise
AEBI Q1 2026 Earnings EPS Misses Estimates Yet Stock Edges Higher
Lightbridge Corporation Q1 2026 Earnings Continued Investment in Nuclear Fuel Technology Amidst No Revenue